These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 3037889

  • 1. Clinical experience with converting-enzyme inhibitors in hypertension.
    Weber MA.
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness and safety of captopril (Tensiomin) in patients with hypertension.
    Török E, Bíró V, Wagner M, Kósa E, Podmaniczky M, Cseh K.
    Acta Physiol Hung; 1988 Jul; 72 Suppl():51-65. PubMed ID: 2908092
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin-converting enzyme inhibitors: are they all alike?
    Case DB.
    J Clin Hypertens; 1987 Sep; 3(3):243-56. PubMed ID: 2822859
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A, Pedrinelli R, Arzilli F, Abdel-Haq B, Magagna A, Lucarini A, Graziadei L, Nuccorini A, Taddei S.
    Int J Clin Pharmacol Res; 1985 Sep; 5(6):429-38. PubMed ID: 3005182
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of enalapril in moderate to severe essential hypertension.
    Walker JF, Kulaga SF, Kramsch DM.
    J Hypertens Suppl; 1984 Dec; 2(2):S107-11. PubMed ID: 6100871
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 7. Different effects of two angiotensin converting enzyme inhibitors in primary hypertension--a comparison of captopril and enalapril.
    Karlberg BE, Sjöstrand A, Ohman KP.
    J Hypertens Suppl; 1986 Dec; 4(5):S432-4. PubMed ID: 3033182
    [Abstract] [Full Text] [Related]

  • 8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
    Paran E, Anson O, Neumann L.
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.